TYW2 and neoplasm: From a clinical feasibility perspective, detecting the mRNA or protein levels of TRMT12 in tumor tissues can be used to screen for patients at high risk for drug resistance and guide treatment plan adjustments (such as combining other drugs to reverse drug resistance).